{
  "path": "/aloha-io/title-24/chapter-432/section-432-1-616/",
  "title": "Cancer treatment",
  "type": "hrs_section",
  "structure": {
    "volume": "9",
    "chapter": "432",
    "section": "432:1-616"
  },
  
  "prev": "https://sammade.github.io/aloha-io/title-24/chapter-432/section-432-1-615/",
  
  
  "next": "https://sammade.github.io/aloha-io/title-24/chapter-432/section-432-1-617/",
  
  "context": "ยง432:1-616 Cancer treatment. (a) All individual and group hospital and medical service plan contracts that include coverage or benefits for the treatment of cancer shall provide payment or reimbursement for all types of chemotherapy that are considered medically necessary as defined in section 432E-1.4. (b) The cost-sharing for generic and non-generic oral chemotherapy shall be provided at the same or lower amount or percentage as is applied to generic and non-generic intravenously administered chemotherapy; provided that an insurer shall not increase the cost-share for intravenously administered chemotherapy in order to achieve compliance with this subsection. &amp;copy; Individual and group hospital and medical service plan contracts shall not increase enrollee cost-sharing for non-generic medications used for the treatment of cancer to any greater extent than such policies increase enrollee cost-sharing for other covered non-generic medication. (d) For the purposes of this section: &amp;ldquo;Cost-share&amp;rdquo; or &amp;ldquo;cost-sharing&amp;rdquo; means copayment, coinsurance, or deductible provisions applicable to coverage for medications or treatments. &amp;ldquo;Intravenously administered chemotherapy&amp;rdquo; means a physician-prescribed cancer treatment that is administered through injection directly into the patient&amp;rsquo;s circulatory system by a physician, physician assistant, nurse practitioner, nurse, or other medical personnel under the supervision of a physician and in a hospital, medical office, or other clinical setting. &amp;ldquo;Oral chemotherapy&amp;rdquo; means a United States Food and Drug Administration-approved, physician-prescribed cancer treatment that is taken orally in the form of a tablet or capsule and may be administered in a hospital, medical office, or other clinical setting or may be delivered to the patient for self-administration under the direction or supervision of a physician outside of a hospital, medical office, or other clinical setting. (e) This section shall not apply to an accident-only, specified disease, hospital indemnity, long-term care, or other limited-benefit health insurance policy. [L 2009, c 168, ยง2; am L 2012, c 30, ยง2] "
}